StatStrip Glucose Hospital Meter System
Prescription Use Blood Glucose Meter For Near-Patient Testing. 510(k) K181043, from Nova Biomedical Corporation (Walham, MA). Product code PZI, class 2.
As of Nov 20, 2026, K181043 is an FDA 510(k) held by Nova Biomedical Corporation, substantially equivalent on Jul 12, 2018 after 84 days, with no recalls tied to it in FDA's recall database.
- Review time: 84 days
- Recalls: 0
- Cited as a predicate by: 4 devices
The StatStrip Glucose Hospital Meter System is intended for point-of-care, in vitro diagnostic, multiple-patient use for the quantitative determination of glucose in capillary finger stick, venous whole blood, arterial whole blood, neonate arterial whole blood, and neonate heel stick specimens throughout all hospital and all professional healthcare settings, including patients receiving intensive…
- StatStrip Glucose Hospital MeterK150281 · Nova Biomedical Corporation · May 6, 2015
- cobas pulse blood glucose monitoring systemK252323 · Roche Diagnostics · Jun 12, 2026
- StatStrip Glucose Hospital Meter SystemK232075 · Nova Biomedical Corporation · Feb 23, 2024
- StatStrip Xpress Glucose Hospital Meter SystemK182552 · Nova Biomedical Corporation · Dec 13, 2018
- StatStrip Xpress 2 Glucose Hospital Meter SystemK182549 · Nova Biomedical Corporation · Dec 13, 2018
- Document
- 510(k) summary (PDF) ↗
- Type
- Dual Track
- Received
- Apr 19, 2018
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files